Latest filing published 10 Jun 2009 for Ernexa Therapeutics Inc., €28.
Insider track record
No signal scores available.
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +2.1%Entry US$352,500.00 · Close at T+365 US$360,000.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kenneth L. Keymer: trading record in brief
Kenneth L. Keymer is a declared insider at 2 companies; the most frequent names are Ernexa Therapeutics Inc. and Popeyes Louisiana Kitchen, Inc. Between 26 January 2006 and 10 June 2009, the trades on record add up to 13 filings.
The open-market record is one-sided, with 9 purchases worth €31k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants. Since January 2009: 9 purchases and no sales on the market.
In size, the median ticket on the buying side is €2,832. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +2.1%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 11 June 2009, reports an open-market purchase of €2,832 in Ernexa Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kenneth L. Keymer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$0.40Common StockSEC:0001019687-09-002081:0Canonical exit: 6 Sept 2009 (T+90)
- 19,900 shares@ US$0.40Common StockSEC:0001019687-09-002081:1Canonical exit: 7 Sept 2009 (T+90)
- 20,000 shares@ US$0.40Common StockSEC:0001019687-09-002081:2Canonical exit: 7 Sept 2009 (T+90)
- 9,900 shares@ US$0.40Common StockSEC:0001019687-09-002081:3Canonical exit: 7 Sept 2009 (T+90)
- 100 shares@ US$0.39Common StockSEC:0001019687-09-002081:4Canonical exit: 7 Sept 2009 (T+90)
- 20,000 shares@ US$0.40Common StockSEC:0001019687-09-002081:5Canonical exit: 8 Sept 2009 (T+90)
- 8,100 shares@ US$0.40Common StockSEC:0001019687-09-002081:7Canonical exit: 8 Sept 2009 (T+90)
- 13,600 shares0Common StockSEC:0001230295-07-000103:0
- 9,282 shares@ US$16.93Common StockSEC:0001230295-07-000099:0
- 13,600 shares0Common StockSEC:0001230295-06-000078:0
- 4,868 shares@ US$16.85Common StockSEC:0001230295-06-000021:0
11 of 11 declarations
